tiprankstipranks
Advertisement
Advertisement

DE:BX20 Stock Latest News

BioXcel Secures DIP Financing Amid Nasdaq Delisting Move
Company AnnouncementsBioXcel Secures DIP Financing Amid Nasdaq Delisting Move
7d ago
8K
BTAI
BioXcel Therapeutics Initiates Chapter 11 and Sale Process
PremiumCompany Announcements
BioXcel Therapeutics Initiates Chapter 11 and Sale Process
11d ago
8K
BTAI
Teva unit bids to acquire neuroscience product from BioXcel Therapeutics
PremiumThe Fly
Teva unit bids to acquire neuroscience product from BioXcel Therapeutics
11d ago
BTAI
TEVA
BioXcel Therapeutics enters asset sale agreement with Teva
PremiumThe Fly
BioXcel Therapeutics enters asset sale agreement with Teva
11d ago
BTAI
TEVA
BioXcel Therapeutics Amends Credit Agreement Amid Liquidity Strain
PremiumCompany Announcements
BioXcel Therapeutics Amends Credit Agreement Amid Liquidity Strain
14d ago
8K
BTAI
BioXcel Therapeutics Amends Credit Agreement, Extends Financing Deadline
PremiumCompany AnnouncementsBioXcel Therapeutics Amends Credit Agreement, Extends Financing Deadline
15d ago
8K
BTAI
BioXcel Therapeutics Amends Credit Agreement, Eases Liquidity Terms
Premium
Company Announcements
BioXcel Therapeutics Amends Credit Agreement, Eases Liquidity Terms
28d ago
8K
BTAI
Is BTAI a Buy, Before Earnings?
Premium
Pre-Earnings
Is BTAI a Buy, Before Earnings?
30d ago
BTAI
BioXcel Therapeutics Amends Credit Agreement, Extends Debt Deadline
PremiumCompany Announcements
BioXcel Therapeutics Amends Credit Agreement, Extends Debt Deadline
1M ago
8K
BTAI
BioXcel Therapeutics Amends Credit Agreement, Tightens Liquidity
PremiumCompany Announcements
BioXcel Therapeutics Amends Credit Agreement, Tightens Liquidity
2M ago
8K
BTAI
BioXcel Therapeutics reports Q1 EPS (54c), consensus (49c)
PremiumThe Fly
BioXcel Therapeutics reports Q1 EPS (54c), consensus (49c)
4M ago
BTAI
Bioxcel Issues Warrants in Private Equity Financing Deal
PremiumCompany Announcements
Bioxcel Issues Warrants in Private Equity Financing Deal
5M ago
8K
BTAI
BioXcel Therapeutics enrolls first patients in BXCL501 trial
PremiumThe FlyBioXcel Therapeutics enrolls first patients in BXCL501 trial
5M ago
BTAI
BioXcel Therapeutics: Undervalued Franchise with IGALMI PDUFA Catalyst Supports Buy Rating Despite Reduced Target
Premium
Ratings
BioXcel Therapeutics: Undervalued Franchise with IGALMI PDUFA Catalyst Supports Buy Rating Despite Reduced Target
5M ago
BTAI
BioXcel Therapeutics price target lowered to $5 from $6 at H.C. Wainwright
Premium
The Fly
BioXcel Therapeutics price target lowered to $5 from $6 at H.C. Wainwright
5M ago
BTAI
FDA Accepts BioXcel sNDA for At-Home IGALMI Use
PremiumCompany Announcements
FDA Accepts BioXcel sNDA for At-Home IGALMI Use
5M ago
8K
BTAI
BioXcel Therapeutics announces FDA acceptance of Igalmi sNDA
PremiumThe Fly
BioXcel Therapeutics announces FDA acceptance of Igalmi sNDA
5M ago
BTAI
Morning Movers: AstraZeneca jumps following tozorakimab trial results
PremiumThe Fly
Morning Movers: AstraZeneca jumps following tozorakimab trial results
5M ago
AGX
AZN
BioXcel Therapeutics reports Q4 EPS (58c), consensus (63c)
PremiumThe Fly
BioXcel Therapeutics reports Q4 EPS (58c), consensus (63c)
5M ago
BTAI
BioXcel Therapeutics initiated with a Buy at Rodman & Renshaw
PremiumThe FlyBioXcel Therapeutics initiated with a Buy at Rodman & Renshaw
6M ago
BTAI
BioXcel Therapeutics Announces Registered Direct Equity Financing
Premium
Company Announcements
BioXcel Therapeutics Announces Registered Direct Equity Financing
6M ago
8K
BTAI
BioXcel price target lowered to $6 from $10 at H.C. Wainwright
Premium
The Fly
BioXcel price target lowered to $6 from $10 at H.C. Wainwright
6M ago
BTAI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >